Equities researchers at Evercore ISI started coverage on shares of Repligen (NASDAQ:RGEN – Get Free Report) in a report ...

Fintel reports that on March 18, 2025, Evercore ISI Group initiated coverage of Repligen (NasdaqGS:RGEN) with a In-Line ...

Fintel reports that on March 18, 2025, Evercore ISI Group initiated coverage of Bio-Techne (NasdaqGS:TECH) with a Outperform ...

In a report released yesterday, Robert Ottenstein from Evercore ISI maintained a Hold rating on PepsiCo (PEP – Research Report), with a price ...

Evercore ISI reissued their in-line rating on shares of EastGroup Properties (NYSE:EGP – Free Report) in a research note released on Monday, MarketBeat reports. The brokerage currently has a $185.00 ...

In a report released today, Chris Baker from Evercore ISI maintained a Hold rating on Vitesse Energy, Inc. (VTS – Research Report). The ...

The investment bank said Bio-Techne is a premium growth asset with a strong core business and growth verticals.

Investing.com -- Evercore ISI upgraded Capital One Financial Corp (NYSE:COF) to "Outperform" from "In Line," focusing on long-term earnings upside from its pending acquisition of Discover ...

Investing.com -- Evercore ISI added Lowe’s (NYSE:LOW) to its tactical outperform list ahead of the company’s fourth-quarter earnings on February 26, given a potential upside in case it ...

On Wednesday, Evercore ISI began coverage on Summit Therapeutics plc (NASDAQ:SMMT) shares, assigning an Outperform rating and setting a price target of $30.00. The $13.65 billion market cap ...

On Wednesday, Evercore ISI began coverage on Summit Therapeutics plc (NASDAQ:SMMT) shares, assigning an Outperform rating and setting a price target of $30.00. The $13.65 billion market cap company, ...